Combination of acupuncture and Chinese herbal formula for elderly adults with mild cognitive impairment: Protocol for a randomized controlled trial
PublisherBioMed Central Ltd.
MetadataShow full item record
AbstractBackground: Mild cognitive impairment (MCI) is known as a transitional status between normal cognitive function and Alzheimer's disease (AD). Acupuncture and Chinese herbal medicines (CHMs) are considered to be beneficial to patients with cognitive impairment. However, it is still unknown whether the combination of the two therapies could optimize the therapeutic effect for MCI. This trial is aimed to evaluate the therapeutic effects of acupuncture and the herbal formula Yishen Granule (YSG) for elderly patients with MCI. Methods/design: This is a multi-sited, patient-blinded, randomized controlled trial (RCT). Two hundred and forty eligible patients will be randomly divided into four groups: A. acupuncture with YSG, B. acupuncture with placebo herbal medicine, C. sham acupuncture with YSG or D. sham acupuncture with placebo herbal medicine. Acupuncture treatment will be given twice a week for 8 weeks and then once a week for 4 weeks. The herbal treatment patients will be given granules daily for 12 weeks, 8 weeks of standard-dose followed by 4 weeks of mid-dose. The primary outcome is scored by the Montreal Cognitive Assessment (MoCA). The secondary outcomes will be scored by the Mini-Mental State Examination (MMSE) and event-related potential (ERP). All the assessments will be conducted at baseline, and at the eighth and 12th week after intervention starts. The follow-up assessments will be performed with the MoCA in the 12th, 24th, and 36th weeks after intervention ends. Intention-to-treat (ITT) analysis will be used in this RCT. Discussion: This RCT will provide us information on the effect of treating MCI patients with only acupuncture, herbal formula as well as the combination of both. The additive effect or synergistic effect of acupuncture and Chinese herbal formula will then be analyzed. Trial registration: This trial is registered with ChiCTR-INR-17011569 on 5 June 2017, and has been approved by the Ethics Committee of Shanghai Municipal Hospital of Traditional Chinese Medicine (2017SHL-KY-05). © 2019 The Author(s).
SponsorsThis RCT is funded by the Shanghai Municipal Commission of Health and Family Planning (Grant No. 2015ZB0504).
Chinese herbal formula
Mild cognitive impairment (MCI)
Randomized controlled trial (RCT)
Identifier to cite or link to this itemhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85061363147&doi=10.1186%2fs13063-019-3212-z&partnerID=40&md5=38bae6336f50b9acde6accac55c611f3; http://hdl.handle.net/10713/8600
- Efficacy and safety assessment of acupuncture and nimodipine to treat mild cognitive impairment after cerebral infarction: a randomized controlled trial.
- Authors: Wang S, Yang H, Zhang J, Zhang B, Liu T, Gan L, Zheng J
- Issue date: 2016 Sep 13
- The synergistic effect of acupuncture and computer-based cognitive training on post-stroke cognitive dysfunction: a study protocol for a randomized controlled trial of 2 × 2 factorial design.
- Authors: Yang S, Ye H, Huang J, Tao J, Jiang C, Lin Z, Zheng G, Chen L
- Issue date: 2014 Aug 7
- The efficacy and safety of the Chinese herbal medicine Di-Tan decoction for treating Alzheimer's disease: protocol for a randomized controlled trial.
- Authors: Chua KK, Wong A, Kwan PW, Song JX, Chen LL, Chan AL, Lu JH, Mok V, Li M
- Issue date: 2015 Apr 30
- Study protocol for a randomised, double-blind, placebo-controlled 12-week pilot phase II trial of Sailuotong (SLT) for cognitive function in older adults with mild cognitive impairment.
- Authors: Steiner GZ, Bensoussan A, Liu J, Hohenberg MI, Chang DH
- Issue date: 2018 Sep 25
- Chinese Herbal Medicine for Mild Cognitive Impairment Using Montreal Cognitive Assessment: A Systematic Review.
- Authors: Dong L, Hyde AJ, Zhang AL, Xue CC, May BH
- Issue date: 2019 Mar 28